急性缺血性脑卒中阿替普酶静脉溶栓后缺血性早期神经功能恶化的独立危险因素分析与风险预测模型构建

    Analysis of the independent risk factors of early ischemic neurological deterioration after intravenous thrombolysis with alteplase in acute ischemic stroke and construction of a risk prediction model

    • 摘要:
      目的: 探讨急性缺血性脑卒中(AIS)病人接受阿替普酶(rt–PA)静脉溶栓(IVT)治疗后发生缺血性早期神经功能恶化(END)的独立危险因素,并基于此构建END风险的临床预测模型。
      方法: 采用回顾性队列研究方法,选取2023年6月至2025年4月高级卒中中心收治并接受标准剂量rt–PAIVT治疗的AIS病人210例,根据溶栓后24 h内是否发生END将病人分为END组和非END组。收集病人基线资料、临床严重程度及实验室检测结果,采用logistic回归分析确定独立危险因素,并基于此构建列线图预测模型和简易加和多因子预测模型。通过受试者工作特征(ROC)曲线评估模型效能。
      结果: END组病人发病–溶栓时间长、入院时高NIHSS评分、溶栓前高收缩压(SBP)、溶栓前随机血糖高水平、TOAST分型大动脉粥样硬化性比例、糖尿病、高空腹血糖比例均高于非END组,差异有统计学意义(P < 0.01)。logistic回归分析确定AIS病人rt–PAIVT后发生缺血性END的独立危险因素(P < 0.05):入院时随机血糖OR(95%CI) = 2.046(1.402~2.987),入院时NIHSS评分OR(95%CI) = 1.825(1.311~2.543),收缩压(SBP)OR(95%CI) = 1.452(1.089~1.937),发病–溶栓时间OR(95%CI) = 1.294(1.023~1.638)。基于上述独立危险因素成功构建END风险预测Nomogram模型和简易加和预测模型。
      结论: 发病–溶栓时间长、溶栓前高SBP、入院时高NIHSS评分、溶栓前随机血糖高水平等,是AIS病人rt–PAIVT后发生缺血性END的独立危险因素。基于上述危险因素构建的风险预测Nomogram模型具有良好的预测能力及临床实用性,有助于早期识别rt–PA溶栓后END高风险病人,为临床进行个体化监测和干预提供依据。

       

      Abstract:
      Objective To investigate the independent risk factors of ischemic early neurological deterioration (END) after intravenous alteplase thrombolysis in patients with acute ischemic stroke (AIS), and construct a clinical prediction model for END risk based on these factors.
      Methods A retrospective cohort study was conducted. A total of 210 AIS patients who were admitted to the Advanced Stroke Center and received standard-dose rt-PAIVT treatment from June 2023 to April 2025 were selected. The patients were divided into the END group and non-END group based on whether END occurred within 24 hours after thrombolysis. The baseline data of patients, clinical severity and laboratory test results were collected. The logistic regression analysis was used to determine the independent risk factors, and based on this, a nomogram prediction model and a simple additive multi-factor prediction model were constructed. The model efficacy was evaluated through the receiver operating characteristic (ROC) curve.
      Results The proportions of patients with longer onset-thrombolysis time, high NIHSS score at admission, high systolic blood pressure (SBP) before thrombolysis, high random blood glucose level before thrombolysis, proportion of large artery atherosclerosis in TOAST classification, diabetes and high fasting blood glucose in the END group were all higher than those in non-END group, and the differences were statistically significant (P < 0.01). The results of logistic regression analysis showed that the independent risk factors of ischemic END in AIS patients after rt-PAIVT (P < 0.05) included the OR(95%CI) of random blood glucose at admission for 2.046 (1.402–2.987), OR(95%CI) of NIHSS score at admission for 1.825 (1.311–2.543) and OR(95%CI) of systolic blood pressure (SBP) for 1.452 (1.089–1.937). The odds ratio (OR) (95%CI) of onset to thrombolysis time was 1.294 (1.023–1.638). Based on the above independent risk factors, a Nomogram model for END risk prediction and simple additive prediction model were successfully constructed.
      Conclusions Long onset-thrombolysis time, high SBP before thrombolysis, high NIHSS score at admission and high random blood glucose level before thrombolysis, etc., are the independent risk factors of ischemic END after rt-PAIVT in AIS patients. The Nomogram model for risk prediction constructed based on the above risk factors has good predictive ability and clinical practicability, which is helpful for the early identification of high-risk END patients after rt-PA thrombolysis, and provides a basis for individualized monitoring and intervention in clinical practice.

       

    /

    返回文章
    返回